Panacea Life Sciences Stock Performance
| PLSH Stock | USD 0.04 0.01 18.37% |
On a scale of 0 to 100, Panacea Life holds a performance score of 1. The company holds a Beta of 3.55, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Panacea Life will likely underperform. Please check Panacea Life's maximum drawdown, as well as the relationship between the expected short fall and day typical price , to make a quick decision on whether Panacea Life's historical price patterns will revert.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Panacea Life Sciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain basic indicators, Panacea Life demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 25.1 K | |
| Total Cashflows From Investing Activities | 522.5 K |
Panacea |
Panacea Life Relative Risk vs. Return Landscape
If you would invest 6.00 in Panacea Life Sciences on November 11, 2025 and sell it today you would lose (2.00) from holding Panacea Life Sciences or give up 33.33% of portfolio value over 90 days. Panacea Life Sciences is currently generating 0.2718% in daily expected returns and assumes 14.1559% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Panacea, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Panacea Life Target Price Odds to finish over Current Price
The tendency of Panacea OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.04 | 90 days | 0.04 | about 91.3 |
Based on a normal probability distribution, the odds of Panacea Life to move above the current price in 90 days from now is about 91.3 (This Panacea Life Sciences probability density function shows the probability of Panacea OTC Stock to fall within a particular range of prices over 90 days) .
Panacea Life Price Density |
| Price |
Predictive Modules for Panacea Life
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Panacea Life Sciences. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Panacea Life's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Panacea Life Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Panacea Life is not an exception. The market had few large corrections towards the Panacea Life's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Panacea Life Sciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Panacea Life within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.19 | |
β | Beta against Dow Jones | 3.55 | |
σ | Overall volatility | 0.02 | |
Ir | Information ratio | 0.03 |
Panacea Life Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Panacea Life for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Panacea Life Sciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Panacea Life had very high historical volatility over the last 90 days | |
| Panacea Life has some characteristics of a very speculative penny stock | |
| Panacea Life has high likelihood to experience some financial distress in the next 2 years | |
| Panacea Life Sciences currently holds 3.26 M in liabilities with Debt to Equity (D/E) ratio of 7.61, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Panacea Life Sciences has a current ratio of 0.61, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Panacea Life until it has trouble settling it off, either with new capital or with free cash flow. So, Panacea Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Panacea Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Panacea to invest in growth at high rates of return. When we think about Panacea Life's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 2.06 M. Net Loss for the year was (4.78 M) with loss before overhead, payroll, taxes, and interest of (4.42 M). | |
| Panacea Life Sciences currently holds about 2.6 M in cash with (3.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 63.0% of Panacea Life outstanding shares are owned by corporate insiders |
Panacea Life Fundamentals Growth
Panacea OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Panacea Life, and Panacea Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Panacea OTC Stock performance.
| Return On Equity | -2.4 | |||
| Return On Asset | -0.18 | |||
| Operating Margin | (3.30) % | |||
| Current Valuation | 18.03 M | |||
| Shares Outstanding | 14.97 M | |||
| Price To Book | 0.46 X | |||
| Price To Sales | 0.55 X | |||
| Revenue | 2.06 M | |||
| EBITDA | (2.71 M) | |||
| Cash And Equivalents | 2.6 M | |||
| Cash Per Share | 0.17 X | |||
| Total Debt | 3.26 M | |||
| Debt To Equity | 7.61 % | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (3.92 M) | |||
| Earnings Per Share | (0.46) X | |||
| Total Asset | 23.78 M | |||
About Panacea Life Performance
By evaluating Panacea Life's fundamental ratios, stakeholders can gain valuable insights into Panacea Life's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Panacea Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Panacea Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Panacea Life Sciences Holdings, Inc., a seed to sale cannabinoid and nutraceutical manufacturer and research company, develops and produces natural pharmaceutical alternatives for consumers and pets. The company was incorporated in 2008 and is headquartered in Greenwood Village, Colorado. Panacea Life operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 29 people.Things to note about Panacea Life Sciences performance evaluation
Checking the ongoing alerts about Panacea Life for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Panacea Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Panacea Life had very high historical volatility over the last 90 days | |
| Panacea Life has some characteristics of a very speculative penny stock | |
| Panacea Life has high likelihood to experience some financial distress in the next 2 years | |
| Panacea Life Sciences currently holds 3.26 M in liabilities with Debt to Equity (D/E) ratio of 7.61, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Panacea Life Sciences has a current ratio of 0.61, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Panacea Life until it has trouble settling it off, either with new capital or with free cash flow. So, Panacea Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Panacea Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Panacea to invest in growth at high rates of return. When we think about Panacea Life's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 2.06 M. Net Loss for the year was (4.78 M) with loss before overhead, payroll, taxes, and interest of (4.42 M). | |
| Panacea Life Sciences currently holds about 2.6 M in cash with (3.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 63.0% of Panacea Life outstanding shares are owned by corporate insiders |
- Analyzing Panacea Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Panacea Life's stock is overvalued or undervalued compared to its peers.
- Examining Panacea Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Panacea Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Panacea Life's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Panacea Life's otc stock. These opinions can provide insight into Panacea Life's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Panacea OTC Stock analysis
When running Panacea Life's price analysis, check to measure Panacea Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Panacea Life is operating at the current time. Most of Panacea Life's value examination focuses on studying past and present price action to predict the probability of Panacea Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Panacea Life's price. Additionally, you may evaluate how the addition of Panacea Life to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |